Pfizer to buy antibiotics business from AstraZeneca

AstraZeneca has agreed to sell its small molecule antibiotics business to Pfizer in a deal that could be valued at more than $1.5 billion.

from Mergers and Acquisitions http://ift.tt/2bmLfmG